Brian Champion
Impact in
- Immunology top 2%
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immunology and Allergy top 2%
Papers in
- Immunology 35
- T-cell and B-cell Immunology 18
- Immunotherapy and Immune Responses 9
-
- Cancer Research and Treatments 12
- Co-authors
- G.A.W. RookJ K SteeleMark AinsworthAnne CookeI M RoittLes SekutKevin ConnollyDavid C. Rayner
- Journals
- Journal for ImmunoTherapy of Cancer (6 papers)Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)Molecular Therapy — Oncolytics (3 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Brian Champion
86 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 120
- Immunology 1.0k
- Immunology and Allergy 242
- Oncology 730
- Genetics 658
- Infectious Diseases 360
Countries citing papers authored by Brian Champion
This map shows the geographic impact of Brian Champion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Champion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Champion more than expected).
Fields of papers citing papers by Brian Champion
This network shows the impact of papers produced by Brian Champion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Champion. The network helps show where Brian Champion may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian Champion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 15 | |
| 2 | 2019 | 10 | |
| 3 | 2018 | 135 | |
| 4 | 2017 | 24 | |
| 5 | 2016 | 7 | |
| 6 | 2016 | 43 | |
| 7 | Evaluation of Enadenotucirev (ColoAd1), an oncolytic Ad11/Ad3 chimeric group B adenovirus, in combination with chemotherapeutic agents in a murine model of ovarian cancer | 2014 | 1 |
| 8 | 2008 | 77 | |
| 9 | 2007 | 29 | |
| 10 | 2006 | 67 | |
| 11 | 2003 | 63 | |
| 12 | 2000 | 7 | |
| 13 | 1995 | 5 | |
| 14 | 1995 | 9 | |
| 15 | 1994 | 485 | |
| 16 | 1993 | 20 | |
| 17 | 1992 | 69 | |
| 18 | 1991 | 85 | |
| 19 | 1990 | 34 | |
| 20 | 1990 | 17 |
About Brian Champion
Brian Champion is a scholar working on Immunology, Biotechnology, Library and Information Sciences, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 90 papers that have together received 2.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (22 papers), Virus-based gene therapy research (21 papers), T-cell and B-cell Immunology (18 papers), CAR-T cell therapy research (16 papers), Cancer Research and Treatments (12 papers), Glycosylation and Glycoproteins Research (10 papers), Immunotherapy and Immune Responses (9 papers) and Developmental Biology and Gene Regulation (7 papers). The work is most often cited by research in Immunology (1.0k citations), Immunology and Allergy (242 citations), Oncology (730 citations), Genetics (658 citations) and Infectious Diseases (360 citations). Brian Champion has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include G.A.W. Rook, J K Steele, Mark Ainsworth, Anne Cooke, I M Roitt, Les Sekut, Kevin Connolly, David C. Rayner, A. Robin Poole and Leonard W. Seymour. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cancer Research, Journal of Clinical Oncology, Molecular Therapy — Oncolytics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.